Amylx Pharmaceuticals Inc vs Ferrari NV — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Ferrari NV trades at $406 (market cap $71.67B). The key difference: Ferrari NV is far larger — about 27.1× Amylx Pharmaceuticals Inc's market cap, and Ferrari NV pays a 1.04% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | RACE | |
|---|---|---|
Market Cap | $2.64B | $71.67B |
Sector | Health | Consumer Cyclical |
52-Week High | $24.19 | $504.09 |
52-Week Low | $7.82 | $314.63 |
Enterprise Value | $2.39B | $73.60B |
Dividend Yield | — | 1.04% |
Trailing returns across standard periods
Latest headlines on both assets
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →Ferrari engineers and manufactures some of the world's most expensive exotic sports cars. The Ferrari brand is synonymous with Formula One racing, exclusivity, Italian design, and state-of-the-art technology. Ferrari also has a captive finance company that provides funding for dealers and clients.
Read more on RACE →